This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
March 9-11, 2026
San Diego Convention CenterSan Diego, CA, USA
BOOK NOW
Menu
BOOK NOW
keyboard_arrow_right

Wednesday 11th March - Main Conference Day Two - PT (Pacific Time, GMT-08:00)

keyboard_arrow_leftSearch & Filter
search
Wednesday 11th March - Main Conference Day Two - PT (Pacific Time, GMT-08:00)
search
Showing 1 of 1 Streams
8:00am - 8:55am
Registration and Morning Coffee
Showing 5 of 5 Streams
8:55am - 9:00am
Chairperson's Opening Remarks: Cell Line Development & Engineering
9:00am - 9:30am
Topic to be Determined
  • Elizabeth H. Scheideman PhD. - Staff Scientist, Vaccine Production Program, VRC, NIAID,, NIH
9:30am - 10:00am
Advanced Cell Line Development Technologies for High-Speed and Flexible Host Gene Modulation
  • Thomas Jostock, PhD - Associate Director, Novartis
10:00am - 10:30am
Great Bay Bio
8:55am - 9:00am
Chairperson's Opening Remarks: Cell Culture & Upstream Processing
9:00am - 9:30am
High-Density CHO Cell Cultures as an Alternative to Perfusion for Productivity Enhancement
  • Hiren Panchal - Principal Investigator, Incyte
9:30am - 10:00am
Advanced Bioreactor Control - How to Achieve Lights Out Automation
10:00am - 10:30am
Sponsored Talk
8:55am - 9:00am
Chairperson's Opening Remarks: Manufacturing Strategy & Bioprocessing 4.0
9:00am - 9:30am
Topic to be Determined
  • Michael Coolbaugh - Head of Advanced Manufacturing Implementation, Sanofi
9:30am - 10:00am
Integrating Continuous Manufacturing: A Practical Roadmap
10:00am - 10:30am
Abzena
8:55am - 9:00am
Chairperson's Opening Remarks: Recovery & Purification
9:00am - 9:30am
The Redox Reaction for Multispecifics
  • Dawn Ericksen-Stapleton - Principal Scientist, Pfizer
9:30am - 10:00am
Topic to be Determined
  • Yoichi Kumada - Professor, Kyoto Institute of Technology
10:00am - 10:30am
Cytiva
8:55am - 9:00am
Chairperson's Opening Remarks: Cell & Gene Therapy Production & Commercialization
9:00am - 9:30am
Scaling genome-edited allogeneic CAR-T manufacturing to increase access to cell therapies
  • Engineering strategies for allogeneic CAR-T cell therapies for improved safety and efficacy
  • Increasing scale of allogeneic cell therapies without compromising quality
  • Improving access to CAR-T therapy with off-the-shelf products


9:30am - 10:00am
Scaling Up Allogeneic Cell Therapy Production
10:00am - 10:30am
Sponsored Talk
Showing 1 of 1 Streams
10:30am - 11:15am
Morning Networking Break in Exhibit Hall
Showing 5 of 5 Streams
11:15am - 11:45am
Accelerated mAb cell line development via bulk pool optimization
  • Shu Wang - Principal Investigator, Incyte
11:45am - 12:15pm
Building Speed into Cell Line Development: Lessons from Accelerated Clinical Programs at BMS
  • Whitney Liu - Senior Scientist, Bristol Myers Squibb
12:15pm - 12:45pm
Sponsored Talk
11:15am - 11:45am
Pushing Productivity Limits – Ultra-High Titer Cell Cultures
11:45am - 12:15pm
Cell Culture Process Intensification
  • Aleah Li - Senior Scientist, Pfizer
12:15pm - 12:45pm
Sponsored Talk
11:15am - 11:45am
Maximizing CMC Efficiency through In-house AD/PD Optimization for External Tech Transfers
  • Discuss the challenges of external tech transfers when outsourcing CDMOs for clinical manufacturing.
  • How to condense timelines and reduce costs through in-house utilization of AD/PD teams to perform parallel development with external partners.
  • Strategies to identify and mitigate risks for allogeneic therapies.
  • Isaura (Alex) Villalba - Senior Research Associate, Tr1X Bio
11:45am - 12:15pm
Fast-Tracking CMC for Accelerated Product Launch
12:15pm - 12:45pm
Sponsored Talk
11:15am - 11:45am
The Role of Digitalization and Data-Driven Optimization on Downstream Processing
  • Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University
11:45am - 12:15pm
Implementing Digital Twins to Support Real-Time Release in DSP
  • John Matthews - Director, Amgen
12:15pm - 12:45pm
Sponsored Talk
11:15am - 11:45am
From Bench to BLA: Critical Attributes of AAV Vector Manufacturing Process Development
  • Mukesh Mayani - Senior Director, Ultragenyx
11:45am - 12:15pm
Topic to be Determined
  • Tony Chikere - Director, Sangamo
12:15pm - 12:45pm
Sponsored Talk
Showing 1 of 1 Streams
12:45pm - 2:00pm
Luncheon in Exhibit Hall
Showing 5 of 5 Streams
2:00pm - 2:30pm
How Early Integration of CLD and Process Development Reduces Risk and Supports Faster, Reliable Scale Up
  • Saurabh Sen - Associate Director, Cell Line Development, Genomic Medicine Unit CMC, Sanofi
2:30pm - 3:00pm
Real-World Examples of Reducing Scale-Up Challenges Through Early, Integrated Development Efforts
  • Vilas Shukla, Ph.D. - Director, Large Molecule Global Engineering Projects, Johnson & Johnson Innovative Medicine
2:00pm - 2:30pm
Adapting CHO Platforms for Viral Vector Production
2:30pm - 3:00pm
Upstream Processing for Novel Modalities
2:00pm - 2:30pm
Keynote Address - Topic to be Determined
  • Paul Hanson - Head of Lifecycle Management, Innovation, and Strategy, Interim Head of, Business Excellence, Global Manufacturing Sciences, Takeda Pharmaceuticals
2:30pm - 3:00pm
Topic to be Determined
  • Jim Fries - CEO, RX-360
2:00pm - 2:30pm
Purification of GLP-1 Peptide Products
2:30pm - 3:00pm
Purification of GLP-1 Peptide Products
2:00pm - 3:00pm
Improving the Cell Therapy Supply Chain

Case studies on digital platforms, logistics coordination, and AI scheduling algorithms improving vein-to-vein times and reliability.

3:00pm - 3:30pm
Improving the Cell Therapy Supply Chain
Showing 1 of 1 Streams
3:30pm - 4:15pm
Afternoon Break in Exhibit Hall
Showing 5 of 5 Streams
4:15pm - 4:45pm
Topic to be Determined
  • Arathi Krishnakumar - Scientific Associate Director, Bristol Myers Squibb
4:45pm - 5:15pm
New Host Cell Platforms and Expression Systems

Presentations on alternative host systems for complex biologics. Talks will highlight modeling and AI-enabled prediction of yield, quality, and downstream compatibility.

5:15pm - 5:45pm
Panel Discussion: Ensuring Cell Line Quality and Stability from Development to Manufacturing

Best practices for maintaining genetic stability and ensuring consistent quality. Panelists will discuss digital monitoring and AI-enabled risk prediction across development to commercial stages.

4:15pm - 4:45pm
Standardizing Raw Material Characterization for Regulatory Acceptance
  • Zvi Kelman - Director, Biomolecular Labeling Laboratory, NIST
4:45pm - 5:15pm
Digital Monitoring and ML Models for Raw Material Tracking
  • Yi Liu - Scientist III and Team Lead, Cell Line Development Vaccine Production Program, VRC/NIAID/NIH
5:15pm - 5:45pm
Panel Discussion: Sustainable and Flexible Upstream Facilities
4:15pm - 4:45pm
Topic to be Determined
  • Ken Hamilton - Director of Process Engineering, Genentech
4:45pm - 5:15pm
Strategy for High-Concentration Sub-Q Biologics – Manufacturing and Device Co-Development

Integrated CMC strategies aligning formulation, device development, and manufacturing planning. Case studies will highlight how modeling and analytics enable cross-functional collaboration, accelerating delivery of combination products.

5:15pm - 5:45pm
Panel Discussion: Sustainable and Flexible Upstream Facilities

A panel exploring how facility design and process strategies maximize sustainability, flexibility, and multiproduct capabilities. Discussions will include modeling and digital tools to enable agile facility operations.

4:15pm - 4:45pm
Ensuring Viral Safety in AAV9 Gene Therapy Program: Potentially Platformable Approach that Delivers Robust Clearance
  • Srivatsan Ramesh - Scientist, BridgeBio Gene Therapy
4:45pm - 5:15pm
The Future of Downstream Processing

Forward-looking discussion on how continuous processing, single-use technologies, and AI-driven purification systems will transform downstream operations by 2030.

5:15pm - 5:45pm
Panel Discussion: Infusing AI into Downstream Processing
4:15pm - 4:45pm
Next-Generation Formulation Approaches for CGT Products

Presentations on innovative formulations, cryopreservation, and vector stabilization. Talks will highlight predictive modeling and data analytics for stability and manufacturability.

4:45pm - 5:15pm
Panel Discussion: Preparing for Commercialization of Advanced Therapies

Panelists will discuss scaling CGT processes for launch, including validation, comparability, COGS, and supply chain readiness. Focus on digital readiness for regulatory filings and scale-up.

5:15pm - 5:45pm
Quality-by-Design for CGT Formulations: Linking DP Attributes to Clinical Handling
Showing 1 of 1 Streams
5:45pm - 5:50pm
Close of Conference
Tuesday 10th March - Main Conference Day One
Filter
Streams
Formats
Choose Day